Clinical Trials

Esophageal Neoplasms

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

123 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03914443 2025-05-31

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

Phase 1 Completed

37 enrolled

Esophageal Squamous Cell Carcinoma

NCT06156514 2025-05-28

MICHELE

Phase 3 Recruiting

140 enrolled

Phase 2 Active not recruiting

Locally Advanced Cervical Cancer

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

44 enrolled

Recurrence

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

200 enrolled

Breast

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Phase 2 Not yet recruiting

45 enrolled

Phase EARLY_PHASE1 Unknown

Endometrial Neoplasms

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

40 enrolled

EGFR Positive Non-small Cell Lung Cancer

NCT04265274 2023-10-06

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05551767 2022-09-23

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

120 enrolled

Head and Neck Neoplasms

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

289 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05007145 2021-12-21

REVO

92 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04063683 2021-08-24

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

47 enrolled

Esophageal Squamous Cell Carcinoma

NCT05013697 2021-08-19

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

48 enrolled

Esophageal Neoplasms

NCT02778308 2021-04-06

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

Phase NA Completed

100 enrolled

Gallbladder Neoplasms

NCT02414685 2020-08-07

TIP

19 enrolled

Neoplasms, Germ Cell and Embryonal

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

EndocrineGastrointestinalNET

112 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

584 enrolled

Esophageal Neoplasms

NCT01939418 2017-10-03

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Phase 1/2 Terminated

23 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00450203 2016-12-01

ST03

Phase 2/3 Unknown

1,103 enrolled

Oesophagogastric Cancer

NCT02957266 2016-11-15

CERVIPIB

Phase 3 Unknown

400 enrolled

Uterine Cervical Neoplasms

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

100 enrolled

Adenocarcinoma of Lung

NCT01356303 2016-05-13

TAXIS01

Phase 2 Suspended

50 enrolled

Lung Neoplasms

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

15 enrolled

Uterine Cervical Neoplasms

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

18 enrolled

Nasopharyngeal Carcinoma

NCT01356368 2014-01-22

Customizing

Phase 2 Terminated

3 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

62 enrolled

Small Cell Lung Carcinoma

NCT00620269 2011-11-07

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

212 enrolled

Lung Neoplasms

NCT00122746 2011-10-13

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

Phase 3 Unknown

322 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT00686322 2011-09-15

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Phase 4 Completed

6 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00563862 2011-06-16

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Phase NA Terminated

465 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

NCT00452881 2010-10-25

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

151 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 1/2 Unknown

74 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00563927 2010-07-07

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Phase NA Unknown

340 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

NCT00980603 2009-09-21

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

144 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00886028 2009-04-22

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

31 enrolled

Mesothelioma, Malignant

NCT00559351 2007-11-16

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Phase 3 Terminated

84 enrolled